☰

Katie L. Propst, Ph.D. - Publications

Affiliations: 
2011 Microbiology, Immunology, & Pathology Colorado State University, Fort Collins, CO 
Area:
Microbiology Biology, Immunology
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Kvitko BH, Goodyear A, Propst KL, Dow SW, Schweizer HP. Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis. Plos Neglected Tropical Diseases. 6: e1715. PMID 22745846 DOI: 10.1371/Journal.Pntd.0001715  0.556
2011 Norris MH, Propst KL, Kang Y, Dow SW, Schweizer HP, Hoang TT. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice. Infection and Immunity. 79: 4010-8. PMID 21807903 DOI: 10.1128/Iai.05044-11  0.622
2010 Whitlock GC, Deeraksa A, Qazi O, Judy BM, Taylor K, Propst KL, Duffy AJ, Johnson K, Kitto GB, Brown KA, Dow SW, Torres AG, Estes DM. Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge. Procedia in Vaccinology. 2. PMID 24379895 DOI: 10.1016/J.Provac.2010.03.013  0.353
2010 Propst KL, Mima T, Choi KH, Dow SW, Schweizer HP. A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Infection and Immunity. 78: 3136-43. PMID 20404077 DOI: 10.1128/Iai.01313-09  0.626
2010 Propst KL, Troyer RM, Kellihan LM, Schweizer HP, Dow SW. Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrobial Agents and Chemotherapy. 54: 1785-92. PMID 20176901 DOI: 10.1128/Aac.01513-09  0.524
2009 Trunck LA, Propst KL, Wuthiekanun V, Tuanyok A, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Peacock SJ, Keim P, Dow SW, Schweizer HP. Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. Plos Neglected Tropical Diseases. 3: e519. PMID 19771149 DOI: 10.1371/Journal.Pntd.0000519  0.498
2009 Troyer RM, Propst KL, Fairman J, Bosio CM, Dow SW. Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis Vaccine. 27: 4424-4433. PMID 19490961 DOI: 10.1016/J.Vaccine.2009.05.041  0.349
2009 Goodyear A, Kellihan L, Bielefeldt-Ohmann H, Troyer R, Propst K, Dow S. Protection from pneumonic infection with burkholderia species by inhalational immunotherapy. Infection and Immunity. 77: 1579-88. PMID 19179415 DOI: 10.1128/Iai.01384-08  0.353
2001 Schweizer HP, Hoang TT, Propst KL, Ornelas HR, Karkhoff-Schweizer RR. Vector design and development of host systems for Pseudomonas. Genetic Engineering. 23: 69-81. PMID 11570107 DOI: 10.1007/0-306-47572-3_5  0.553
Show low-probability matches.